Topics / Pathology (Biology)

Weekly issue

Pathology (Biology) Papers of the Week

The 20 most important new Pathology (Biology) papers of the past week, ranked by potential impact. A new issue comes out every Monday, covering the previous Monday-to-Sunday week.

Nov 2 - 8, 2026 · Updated

Prefer new papers every day? It's free.Daily Pathology Papers (Biology) →
  1. 1
  2. 2
    Characterization of Plasma Misfolded Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis

    We utilized an SOD1/G93A mouse model and a cohort of 160 ALS patients, including four with SOD1 mutations, 12 with non-SOD1 mutations (C9orf72, TARDBP, FUS, OPTN), and 144 with nongenetic ALS.

  3. 3
  4. 4
    Decoder-FFPE-seq Enables Sensitive, Genome-wide Spatial Transcriptomics of Archival Tissues at Single-cell Resolution

    Formalin-fixed paraffin-embedded (FFPE) tissue-compatible spatial transcriptomics (ST) is transforming biology and histopathology, but achieving high sensitivity, genome-wide coverage, single-cell resolution, and researcher accessibility remains challenging. To address these challenges, we here present a dendrimeric DNA coordinate barcoding design for FFPE tissue-adapted spatial RNA sequencing (Decoder-FFPE-seq) by integrating RNA-to-DNA probe conversion with blotting-assisted barcoding.

  5. 5
    Fibromyalgia and Dysautonomia: Towards A Neurophysiological Framework for Personalized Management

    Increasing evidence suggests that autonomic dysfunction may contribute to this multisystem presentation, with abnormalities in heart rate variability (HRV), orthostatic cardiovascular regulation and postural orthostatic tachycardia syndrome (POTS) reported in patients with FM. This narrative review examines the evidence for dysautonomia in FM, its relationship with peripheral and central mechanisms, approaches to clinical assessment, and current and emerging strategies for mechanism informed management.

Get papers like these the day they come out, not a week later.

Follow this category
  1. 6
    Interpretable Deep Learning Maps Spatial Morphological Phenotypes to HCC and LUAD Survival

    Here, we introduce MorphX, an interpretable framework that predicts patient survival by explicitly decoding multi-scale morphological patterns from whole-slide images.

  2. 7
    A Clinical Multimodal Vision Language Foundation Model with Fine-grain Explainability

    Despite their considerable promise, many current medical foundation models remain modality specific and lack transparent reasoning, limiting clinical adoption. To address this gap, we introduce Explainable Vision Language Foundation Model for Medicine (EVLF-FM), a multimodal vision language foundation model that combines broad diagnostic capabilities with fine-grained explainability.

  3. 8
    Enhanced CfDNA Methylation Profiling By Detection and Correction of Jagged Ends

    Here we present JEEPERS, a framework to detect and correct jagged-end-induced methylation errors while preserving duplex integrity and native methylation patterns.

  4. 9
    ESX-5 Component EccB 5 Targets GSDMD to Drive Pyroptosis and Promote Mtb Dissemination

    Here we identify the ESX-5 component EccB as a mycobacterial virulence factor that binds gasdermin D (GSDMD) and potentiates pathogenic pyroptosis.

  5. 10
    The Evolving Landscape of DLL3-directed Therapeutics in Small Cell Lung Cancer

    This review critically examines the evolving portfolio of DLL3-targeted therapies across three principal modalities: T-cell engagers, ADCs, and chimeric antigen receptor T-cell (CAR-T) therapies.

  6. 11
    Clostridium Perfringens Delta Toxin Targets CD9 to Drive NEC and Brain Injury

    Here we identify Clostridium perfringens pathobionts containing Delta toxin in the gut microbiome of individuals with severe and fatal NEC.

  7. 12
    MRI-based Biomarkers for Risk Stratification and Assessment of Treatment Response in Metabolic Dysfunction-associated Steatotic Liver Disease

    Artificial intelligence may broaden access by automating analysis and enabling PDFF from routine MRI. We review the evidence supporting these biomarkers for diagnosis, prognosis and regulatory use, and their role in clinical trials and in treatment decisions for approved MASH therapies.

  8. 13
    A Rare TMEM175 Mutation Drives Parkinson's Disease Pathology By Disrupting Proton Gating and Lysosomal Acidification

    Collectively, our work provides genetic and pharmacological evidence that severe loss-of-function mutations may contribute causally to the onset age and pathogenesis of PD and identifies lysosomal proton channels and transporters as potential therapeutic targets for PD intervention.

  9. 14
    The Staphylococcal Protease SspA Perturbs The Epidermal Barrier and Promotes IL-22-driven Inflammation in Allergen-exposed Skin

    SspA and house dust mite extract (HDM), when epicutaneously applied in combination, cause interleukin (IL)-22-dependent atopic dermatitis-like skin disease in mice. Spatial single-cell analysis and immunophenotyping of lesional skin of these mice reveal massive elongation and branching of epidermal nerve fibers and the formation of T cells simultaneously producing IL-13 and IL-22.

  10. 15
    Multimodal Spatial Transcriptomics Redefines Cortical Pathology in Huntington's Disease

    We have developed a multimodal spatial transcriptomics approach that enables the definition of transcriptional programs with subcellular resolution, somatic CAG repeat lengths, and eight other pathology markers, including HTT inclusions, in every cell of intact brain sections.

  11. 16
  12. 17
    LAMP2A Gene Therapy Mitigates Parkinson's Disease-related Pathology in Nonhuman Primates

    To test translational relevance, we examined whether increasing LAMP2A expression in nonhuman primates could mitigate α-synucleinopathy induced by injections of Parkinson's disease patient-derived Lewy body (LB) extract.

  13. 18
    A Single Liver-sparing Myotropic AAV Ameliorates Muscular Dystrophy in Humanized Mice By Base Editing

    Here, we describe a single AAV vector encoding a compact adenine base editor, SlugABE8e, and a single-guide RNA, which enable efficient editing in a humanized DMD mouse model at a lower dose using the muscle-tropic MyoAAV4 capsid.

  14. 19
    Plasma P-Tau217 and NfL Longitudinal Changes Across Neurodegenerative Diseases: Impact of Α-Synuclein in Alzheimer Disease

    We aimed to characterize longitudinal changes (36 months) in plasma p-tau217 and NfL across neurodegenerative and non-neurodegenerative cognitive disorders and to examine biomarker trajectories according to aSyn pathology status within AD.

  15. 20
    Genetic Variants Shape Single-cell Chromatin Accessibility and Disease Risk

    Here we present single-cell assay for transposase-accessible chromatin with sequencing of 3.5 million peripheral blood mononuclear cells from 1,042 donors with matched whole-genome sequencing.